Swiss National Bank’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-59,000
| Closed | -$934K | – | 2424 |
|
|
2024
Q4 | $934K | Buy |
59,000
+2,700
| +5% | +$42.7K | ﹤0.01% | 2228 |
|
|
2024
Q3 | $3.27M | Sell |
56,300
-500
| -0.9% | -$29K | ﹤0.01% | 1573 |
|
|
2024
Q2 | $2.6M | Buy |
56,800
+6,900
| +14% | +$315K | ﹤0.01% | 1678 |
|
|
2024
Q1 | $3.3M | Buy |
49,900
+9,000
| +22% | +$596K | ﹤0.01% | 1561 |
|
|
2023
Q4 | $1.63M | Sell |
40,900
-4,700
| -10% | -$187K | ﹤0.01% | 1968 |
|
|
2023
Q3 | $1.45M | Buy |
45,600
+2,100
| +5% | +$66.9K | ﹤0.01% | 2030 |
|
|
2023
Q2 | $1.75M | Buy |
43,500
+7,800
| +22% | +$313K | ﹤0.01% | 1973 |
|
|
2023
Q1 | $1.52M | Sell |
35,700
-1,600
| -4% | -$68.3K | ﹤0.01% | 2009 |
|
|
2022
Q4 | $1.79M | Buy |
37,300
+3,100
| +9% | +$149K | ﹤0.01% | 1957 |
|
|
2022
Q3 | $1.29M | Buy |
34,200
+1,100
| +3% | +$41.4K | ﹤0.01% | 2181 |
|
|
2022
Q2 | $915K | Buy |
33,100
+2,700
| +9% | +$74.6K | ﹤0.01% | 2416 |
|
|
2022
Q1 | $1.65M | Buy |
30,400
+2,300
| +8% | +$125K | ﹤0.01% | 2138 |
|
|
2021
Q4 | $1.64M | Hold |
28,100
| – | – | ﹤0.01% | 2185 |
|
|
2021
Q3 | $1.11M | Hold |
28,100
| – | – | ﹤0.01% | 2383 |
|
|
2021
Q2 | $1.19M | Buy |
28,100
+7,500
| +36% | +$318K | ﹤0.01% | 2402 |
|
|
2021
Q1 | $1.27M | Hold |
20,600
| – | – | ﹤0.01% | 2259 |
|
|
2020
Q4 | $1.45M | Buy |
+20,600
| New | +$1.45M | ﹤0.01% | 2095 |
|